Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only scopolamine in transdermal dose form (medicinal product form) | Has manufactured dose form | Transdermal dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only scopolamine in transdermal dose form (medicinal product form) | Count of base of active ingredient | 1 | false | Inferred relationship | Some | ||
| Product containing only scopolamine in transdermal dose form (medicinal product form) | Is a | Hyoscine only product | true | Inferred relationship | Some | ||
| Product containing only scopolamine in transdermal dose form (medicinal product form) | Is a | Product containing scopolamine in transdermal dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only scopolamine in transdermal dose form (medicinal product form) | Has active ingredient | Scopolamine (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only scopolamine in transdermal dose form (medicinal product form) | Is a | Medicinal product acting as antiemetic agent (product) | true | Inferred relationship | Some | ||
| Product containing only scopolamine in transdermal dose form (medicinal product form) | Plays role | Antiemetic therapeutic role (role) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Hyoscine 13.889 microgram/hour prolonged-release transdermal patch | Is a | True | Product containing only scopolamine in transdermal dose form (medicinal product form) | Inferred relationship | Some |
Reference Sets
FHIR